BE study involving injectable device [Design Issues]

posted by Dr_Dan  – Germany, 2014-07-25 14:18 (4351 d 14:59 ago) – Posting: # 13312
Views: 6,825

Dear John
In order to understand your question could you please provide some more information? Are you talking about some kind of intramuscular/subcutaneous depot formulation? Is the device biodegradable or must it be removed by surgery?
In general such devices act over a long period of time and therefore you will end up with a parallel group design. Variability strongly depends on the solubility of the drug, the release mechanism and the metabolism of the study participants. To my experience the variability will be comparably high.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
137 visitors (0 registered, 137 guests [including 36 identified bots]).
Forum time: 05:17 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5